Lancet (London, England)
Published

The regulatory rollercoaster continues-EMA refuses donanemab

Authors

Bart De Strooper, Christian Haass, John Hardy, Henrik Zetterberg
Read More

Abstract

Lancet. 2025 May 2:S0140-6736(25)00833-5. doi: 10.1016/S0140-6736(25)00833-5. Online ahead of print.

NO ABSTRACT

PMID:40324447 | DOI:10.1016/S0140-6736(25)00833-5

UK DRI Authors

Bart De Strooper

Prof Bart De Strooper

Group Leader

Investigating the cellular reaction to amyloid beta and tau protein in Alzheimer's disease

Prof Bart De Strooper
John Hardy

Prof Sir John Hardy

Group Leader

Harnessing genetics to build a better understanding of dementia

Prof Sir John Hardy
Profile picture of Henrik Zetterberg

Prof Henrik Zetterberg

Group Leader

Pioneering the development of fluid biomarkers for dementia

Prof Henrik Zetterberg